Non-regulatory Press releases

Malmö, 02 September 2024 Download the press release as PDF here Pila Pharma AB (publ) (FN STO: PILA) announces that recently appointed CEO Gustav H. Gram has purchased additional shares. The purchases occurred on Wednesday, 30 August, where 29.375 shares in the company were acquired. The shares were purchased at an average price of SEK 5,1768.___Mr. Gram's direct holdings in Pila Pharma AB…

Malmö, August 26, 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) hereby invites interested investors to participate in our scheduled events in the coming week:___________Stokk.io Online Webinar - H2 Report (ONLINE)Tuesday, August 27, 2024 from 12:00 CET Malmö, August 26, 2024 Aktiespararna Online Life Science Day (ONLINE)Wednesday, August 28, 2024 from 20:00 CETRedeye…

Malmö, 26 June 2024 Download the press release as PDF here PILA PHARMA today announces it’s participation in and co-sponsorship of the 41st International Symposium on Diabetes and Nutrition, organized by the Diabetes and Nutrition Study Group (DNSG).The conference is taking place in Uppsala, Sweden from June 27-30. PILA PHARMA has been invited to participate by the chairman of the DNSG organizing committee, Professor Ulf Risérus, Uppsala University, Sweden…

Malmö, 11 June 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present tomorrow at the Aktiespararna's "Store Aktiedagarna" event. We hereby invite interested parties and investors to follow the event. It will take place tomorrow, Wednesday 12 June 2024 at 08:00 CET. The presentation is held physically in Stockholm,…

Malmö, 23 May 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) announces that it will present today at the Redeye Theme: Diabetes. We hereby invite interested parties and investors to follow the event. It will take place today, Thursday 23 May 2024 at 09:30 CEST. The presentation is held physically in Redeye's studio…